Alcon Inc (ALC)

Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs

Non-exclusive license agreement for the development and commercialization of novel post-operative light...

Form SD - Specialized disclosure report

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

New Product Launches Drive Alcon's First-Quarter 2026 Growth as Momentum from Unity and Tryptyr Builds

First-quarter 2026 sales of $2.7 billion, up 10% on a reported basis, or up 6% constant currency1 (cc), versus first-quarter 2025 First-quarter...

Alcon Announces Results of 2026 Annual General Meeting

Shareholders approve all agenda items presented R. Scott Herren elected as new independent member of the Board 2025 Compensation Report and...

Systane se joint aux Blue Jays de Toronto à titre de goutte oculaire officielle pour sensibiliser les Canadiens à la sécheresse oculaire

Un nouveau partenariat visant à sensibiliser les gens à la sécheresse oculaire, une condition qui touche...

Alcon Launches Clareon TruPlus, Enhanced Design Monofocal and Toric IOLs, at ASCRS 2026

TruPlus is designed to increase depth of focus while maintaining the high-quality distance vision surgeons expect from a monofocal IOL1,2...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Alcon Publishes Agenda for 2026 Annual General Meeting

Alcon welcomes its shareholders to its fourth in-person AGM Alcon Board of Directors proposes to elect R. Scott Herren as a new independent...

Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that it has entered into an...

Alcon Surpasses 175 Million IOLs Implanted Globally

Milestone includes more than 6 million PCIOL implants worldwide, with PanOptix and Vivity leading globally in trifocal and EDOF IOLs1,* PanOptix...

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]